Yahoo Web Search

Search results

    • Q1 2024 Kymera Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 hour ago

      Our first-in-class oral IRAK4 degrader 84 seven four, is progressing into Phase two trials in hidradenitis suppurativa and atopic dermatitis. These trials are being conducted by Sanofi ...

    • Diana Blankman

      US News & World Report· 20 hours ago

      In her current role at Sanofi, Diana leads US Corporate Social Responsibility, accountable for the development and implementation of the company’s social impact, employee ...